Apheresis in thoracic organ transplantation

Area of Science:

• Immunology
• Transplantation Medicine
• Medical Technology

Background:

• Current immunosuppressants like cyclosporine and tacrolimus only partially address thoracic organ transplant rejection.
• Acute and chronic rejection remain significant challenges in transplantation outcomes.

Purpose of the Study:

• To explore the role and potential of apheresis techniques in modifying allograft rejection.
• To evaluate specific apheresis methods as adjuncts or alternatives to conventional immunosuppression.

Main Methods:

• Review of apheresis techniques including plasmapheresis, extracorporeal photochemotherapy, and immunoadsorption.
• Analysis of their application in managing alloantibody burdens and acute humoral rejection.
• Assessment of potential benefits in reducing graft vasculopathy.

Main Results:

• Plasmapheresis effectively reduces alloantibody levels, enabling transplantation in highly sensitized patients and treating acute humoral rejection.
• Extracorporeal photochemotherapy shows potential as a synergistic therapy, possibly mitigating graft vasculopathy.
• Advancements in immunoadsorption techniques are expanding the use of apheresis in transplantation.

Conclusions:

• Apheresis techniques represent a valuable addition to managing thoracic organ transplant rejection.
• These methods offer novel approaches for patients with high alloantibody levels and acute rejection episodes.
• Further integration of apheresis holds promise for improving long-term transplant success.